From 2015: "The Board of Directors of the American International Health Alliance (AIHA) today announced that David Greeley has been appointed as the new President and Chief Executive Officer of the Washington, DC-based nonprofit organization. Mr. Greeley brings with him more than 30 years of experience working for international development and nonprofit health organizations, as well as for the pharmaceutical company Merck & Co., Inc. Mr. Greeley succeeds retiring Executive Director and AIHA founder, James P. Smith.
“We are excited to welcome David,” said Dr. Roger Bulger, Chairman of AIHA’s Board of Directors. “His vast and impressive experience in forging public-private partnerships in global health and development, combined with his proven leadership skills, is exactly what we need to further support our twinning partners around the world and expand our programs,” added Bulger.
Mr. Greeley has travelled to 90 countries and worked for extensive periods in Africa, Asia, Latin America, and the United States. He has health expertise in HIV/AIDS, TB, malaria, family planning, and maternal and child health, as well as experience in public affairs, communications, policy/advocacy, resource mobilization, and program management. Immediately prior to joining AIHA, he served as President and Chief Executive Officer of Accordia Global Health Foundation, whose mission is to build healthcare capacity in Africa. Before that, Mr. Greeley worked for the international nonprofit organizations Global Alliance for TB Drug Development (TB Alliance), FHI360, Population Services International (PSI), and CARE. Mr. Greeley also worked for Merck & Co., Inc. for more than a decade, where he focused on improving access to medicines in the developing world and emerging markets, primarily through creating and managing public-private partnerships." 
"Mr. Greeley has over 25 years of experience with international nonprofit health and development organizations and more than 10 years of experience in the private sector. Immediately prior to joining AIHA, he served as President and CEO of Accordia Global Health Foundation. As the flagship corporate responsibility program of the pharmaceutical company Pfizer, Inc., Accordia’s mission is to improve healthcare capacity in Africa. Over the past decade, the Foundation established and helped develop the now renowned Infectious Disease Institute (IDI) in Uganda.
"Previously, Mr. Greeley served as Senior Vice President of External Affairs for the Global Alliance for TB Drug Development (TB Alliance), a product development partnership working to bring new tuberculosis treatments to the market. At the TB Alliance, he was responsible for resource mobilization, policy and advocacy, community engagement, and the integration of communications into the external affairs agenda. Prior to the TB Alliance, Mr. Greeley served as Vice President for the Center for Private Sector Health Initiatives at AED, (which subsequently became FHI360), where he managed a team of some 50 individuals and a project portfolio of approximately $35 million annually. The Center’s projects spanned malaria, reproductive health, and HIV/AIDS, and operated in Asia, Africa, and the Caribbean.
"From 1998-2008, Mr. Greeley worked for Merck & Co. Inc., first leading the public affairs, communications, and policy function for the Latin American division and then heading up the company’s global HIV/AIDS programs, policy, and stakeholder relations within the Office of Corporate Responsibility. Prior to Merck, he worked for Population Services International (PSI) for more than seven years. There he created the organization’s new business development department and led operations in India before being tapped to oversee PSI programming throughout Asia, as well as the business development department. At CARE, Mr. Greeley worked in Indonesia, Belize, and Niger in various programmatic and management capacities. He served as a Peace Corps Volunteer in Burkina Faso, West Africa, in the early 1980s." 
Resources and articles